Masafumi Ota

1.3k citations
16 papers · 1.1k indexed · h-index 14
Topics
Retinal Diseases and Treatments (16 papers)Retinal Imaging and Analysis (9 papers)Retinal and Optic Conditions (8 papers)
Partner nations
Japan

In The Last Decade

Masafumi Ota

16 papers receiving 1.0k citations

Peers

Masafumi Ota
Comparison fields: 5 of 36
  • Ophthalmology 1.1k
  • Radiology, Nuclear Medicine and Imaging 816
  • Molecular Biology 121
  • Biomedical Engineering 62
  • Neurology 40
Replace Luca Ventre with:
Luca Ventre Italy
Siamak Ansari‐Shahrezaei Austria
Steven Agemy United States
Sławomir Teper Poland
R. M. S. Yuson United States
Shin Yoshitake Japan
Yumiko Akagi-Kurashige Japan
Sonja Prager Austria
Byung Gil Moon South Korea
Arghavan Almony United States
Masafumi Ota relative to Luca Ventre Italy Luca Ventre's profile →
Citations per field
00.5×3.4×
Luca Ventre · 1×
Citations per year

Countries citing papers authored by Masafumi Ota

Since Specialization
Citations

This map shows the geographic impact of Masafumi Ota's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masafumi Ota with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masafumi Ota more than expected).

Fields of papers citing papers by Masafumi Ota

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Masafumi Ota. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masafumi Ota. The network helps show where Masafumi Ota may publish in the future.

Co-authorship network of co-authors of Masafumi Ota

This figure shows the co-authorship network connecting the top 25 collaborators of Masafumi Ota. A scholar is included among the top collaborators of Masafumi Ota based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Masafumi Ota. Masafumi Ota is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
#WorkIndexed citations
1 9
2 23
3 95
4 85
5 81
6 8
7 94
8 92
9 106
10 93
11 50
12 38
13 25
14 85
15 119
16 71

About Masafumi Ota

Masafumi Ota is a scholar working on Ophthalmology, Radiology, Nuclear Medicine and Imaging and Molecular Biology, having authored 16 papers that have together received 1.1k indexed citations. Recurring topics across this work include Retinal Diseases and Treatments (16 papers), Retinal Imaging and Analysis (9 papers) and Retinal and Optic Conditions (8 papers). The work is most often cited by research in Ophthalmology (1.1k citations), Radiology, Nuclear Medicine and Imaging (816 citations) and Neurology (40 citations). Masafumi Ota has collaborated with scholars based in Japan. Frequent co-authors include Nagahisa Yoshimura, Atsushi Sakamoto, Akitaka Tsujikawa, Tomoaki Murakami, Kazuaki Miyamoto, Kazuaki Nishijima, Mihori Kita, Takahiro Horii, Yuriko Kotera and Noritatsu Yamaike. Their work appears in journals such as Ophthalmology, American Journal of Ophthalmology and Retina.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026